Pulmonic Valve REplacement Multi-discIpline EMEA Registry

CompletedOBSERVATIONAL
Enrollment

127

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

July 31, 2013

Study Completion Date

December 19, 2017

Conditions
Pulmonary RegurgitationPulmonary InsufficiencyPulmonary Stenosis
Interventions
DEVICE

Transcatheter Pulmonic Valve Replacement (TPVR) (Edwards SAPIEN™ THV)

The Edwards SAPIEN™ THV is a biological heart valve manufactured with treated bovine pericardial tissue that is mounted into a balloon expandable stainless steel open cell stent. The Edwards SAPIEN™ THV is available in two sizes (23 and 26mm) and is designed for transcatheter implantation in patients with regurgitant pulmonary valved conduit with or without stenosis. This device is commercially available and is used according the current IFU.

Trial Locations (16)

3000

University Hospital Leuven, Leuven

11211

King Faisal Specialist Hospital & Research Centre, Riyadh

11625

Prince Sultan Cardiac Centre, Riyadh

20097

Policlinico San Donato, San Donato Milanese

32545

Herz und Diabeteszentrum NRW, Bad Oeynhausen

34303

Mehmet Akif Ersoy Thoracic & Cardiovascular Surgery, Istanbul

48149

Universitätsklinikum Münster, Münster

49202

Schneider Children's Medical Center of Israel, Petach Tikvah

80636

Deutsches Herzzentrum München, München

Unknown

German Heart Institute Berlin, Berlin

Mater Misericordiae University Hospital, Dublin

RM 00165

Ospedale Bambino Gesù, Rome

04-628

The Cardinal Stefan Wyszyński Institute of Cardiology, Warsaw

SW3 6NP

Royal Brompton Hospital, London

W1G 8PH

The Heart Hospital, London

M139WL

Manchester Royal Infirmary, Manchester

Sponsors
All Listed Sponsors
lead

Edwards Lifesciences

INDUSTRY